Finance

Beta
Ask
Lists
NASC:OTCMKTS
Can B Corp
$0.013
-16.37%
(-0.0025) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NASC...
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
897.58K
Avg. vol.
23.28K
Volume
148.70K
52-wk high
$0.04
52-wk low
$0.01
Beta
0.63
Shares outstanding
75.84M
No. of employees
12
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
897.58K
Avg. vol.
23.28K
Volume
148.70K
52-wk high
$0.04
52-wk low
$0.01
Beta
0.63
Shares outstanding
75.84M
No. of employees
12
News stories
From sources across the web
About Can B Corp
CEO-
Employees12
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitenascentpharmaholdings.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Revenue
-
-
272.29K
15.27K
Cost of goods sold
-
-
665.47K
415.82K
Cost of revenue
-
-
665.47K
415.82K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1.17M
2.43M
Operating expense
-
-
1.17M
2.43M
Total operating expenses
-
-
1.84M
2.85M
Operating income
-
-
-1.57M
-2.83M
Other non operating income
-
-
1.76K
521.00
EBT including unusual items
-
-
-2.03M
-3.26M
EBT excluding unusual items
-
-
-2.03M
-3.26M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2.03M
-3.26M
Net profit margin
-
-
-745.03%
-21,367.56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-463.37K
-430.17K
Net interest expenses
-
-
-463.37K
-430.17K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-1.54M
-2.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer